secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0001932393-24-000051
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare realigns IGT to AVS segment; recasts 2022-2024 segment revenue and EBIT
--------------------------------------------------------------------------------

- Effective July 1, 2024, Image Guided Therapies moved from Imaging to Ultrasound, renamed Advanced Visualization Solutions (AVS).
- Recast Q2 2024 Imaging revenue $2,171M; AVS revenue $1,249M (Procedural Guidance $668M, Specialized Ultrasound $581M).
- Recast Q2 2024 Segment EBIT: Imaging $208M, AVS $255M, PCS $78M, PDx $200M.
- Total revenue and EBIT unchanged; company now reports four segments: Imaging, AVS, PCS, PDx.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239324000051/0001932393-24-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239324000051/gehc-20241030.htm
  HTML page:      https://secwatch.observer/filing/0001932393-24-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer